Agenus reported $77.12M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Amgen AMGN:US $ 4.33B 1.37B
AstraZeneca AZN:LN 11.54B 4.45B
Bristol Myers Squibb BMY:US $ 9.63B 360M
Celldex Therapeutics CLDX:US $ 20.98M 4.06M
Chemocentryx CCXI:US $ 39.55M 1M
CSL CSL:AU $ 3.8B 417M
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Dynavax Technologies DVAX:US $ 92.2M 43.38M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Genocea Biosciences GNCA:US $ 13.36M 1.19M
Gilead Sciences GILD:US $ 3579M 392M
Glaxosmithkline GSK:US 7.14B 722M
GlaxoSmithKline GSK:LN 7.14B 722M
Immunogen IMGN:US $ 43.44M 873K
Intrexon XON:US $ 47.03M 2.22M
Jiangsu Hengrui Me. 600276:CH 5.06B 113.59M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Macrogenics MGNX:US $ 68.65M 2.39M
Merck MRK:GR 3.93B 105M
Merk MRK:US $ 8328M 1460M
Northwest Biotherapeutics NWBO:US 10.4M 2.56M
Novartis NOVN:VX 10.13B 319M
Novavax NVAX:US $ 485.99M 157.86M
Pfizer PFE:US $ 16447M 3384M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Rigel Pharmaceuticals RIGL:US $ 41.33M 2.01M
Sangamo Biosciences SGMO:US $ 77M 427K
Veracyte VCYT:US $ 77.05M 14.47M
YTE INCY:US $ 577.58M 12.7M